Frankfort, Kentucky, August 19, 2025
News Summary
Kentucky Governor Andy Beshear has officially classified bromazolam, known as ‘Designer Xanax’, as a Schedule 1 controlled substance. This designation allows law enforcement to take action against its sale and possession due to a rise in overdose deaths, with 48 fatalities reported in 2024 alone. Governor Beshear aims to combat the addiction crisis in Kentucky through this regulatory measure, responding to Attorney General Russell Coleman’s concerns about the drug’s high potential for abuse and fatal overdoses. The classification aligns with similar actions taken by other states facing the same issues.
Frankfort, Kentucky – Kentucky Governor Andy Beshear has officially classified bromazolam, also referred to as “Designer Xanax,” as a Schedule 1 controlled substance. This immediate designation enables law enforcement in the state to arrest individuals for the sale or possession of bromazolam, an action taken in response to a surge in overdose deaths related to the drug.
In 2024 alone, there have been 48 reported overdose deaths in Kentucky attributed to bromazolam. This alarming statistic underscores the urgency of the situation, prompting the governor to take regulatory measures to combat the growing threat of addiction in the state.
Governor Beshear has highlighted the significance of this decision, which is part of ongoing campaigns to address the addiction crisis that has been a persistent challenge in Kentucky. The emergency change follows a request made by Attorney General Russell Coleman, who underscored the risks associated with bromazolam, specifically its potential to cause fatal overdoses even with the intake of a single pill.
Law enforcement agencies across the state will now have the authority to enforce stricter regulations surrounding bromazolam, aiming to diminish its accessibility in local communities. Other states that have previously classified bromazolam in a similar manner as a Schedule 1 substance include Nevada, New Mexico, North Dakota, Virginia, and West Virginia. This trend reflects an escalating awareness of the drug’s dangers and a collective effort among several states to tackle its misuse.
The classification of bromazolam as a Schedule 1 substance indicates that it is recognized as having a high potential for abuse and lacks any accepted medical use in treatment within the United States. This designation aligns with the state’s broader initiative aimed at reducing overdose deaths, a goal that has seen progress for three consecutive years under initiatives such as Team Kentucky.
Attorney General Coleman has expressed pride in the collaboration between his office and law enforcement agencies in addressing the threats posed by bromazolam. The joint efforts highlight a unified approach to public safety and health concerns, aiming to protect residents from the devastating effects of this potent substance.
This recent action serves as a call to raise awareness about the dangers of bromazolam and to reinforce the commitment to safeguarding Kentucky’s communities from the escalating challenges posed by substance abuse. The administration remains focused on creating a safer environment free from the threats of addiction while supporting efforts to educate the public about the risks associated with this substance.
Background on Bromazolam
Bromazolam is a drug chemically related to benzodiazepines, known for their sedative and anxiolytic effects. Misuse of benzodiazepines, including bromazolam, has been linked to significant health risks, including addiction, overdose, and death. The urgent actions taken by the state reflect a serious concern about the rise of such substances in the region and their implications for public health.
Conclusion
As Kentucky navigates its ongoing struggle with opioid and substance abuse, the recent classification of bromazolam as a Schedule 1 controlled substance serves as a critical measure aimed at mitigating the risks associated with its use and preventing further loss of life.
FAQ
What is bromazolam?
Bromazolam is a drug related to benzodiazepines, often referred to as “Designer Xanax.” It has sedative effects and can be highly addictive.
Why has it been classified as a Schedule 1 controlled substance?
Bromazolam is deemed to have a high potential for abuse and no accepted medical use in the United States, which warranted its classification as a Schedule 1 substance.
What does this classification mean for Kentucky residents?
This classification allows law enforcement to arrest individuals for the possession or sale of bromazolam, tightening restrictions on access to the drug.
What are the overdose statistics for bromazolam in Kentucky?
In 2024, there have been 48 reported overdose deaths in Kentucky connected to bromazolam, highlighting the urgent need for regulation.
Have other states taken similar action?
Yes, states such as Nevada, New Mexico, North Dakota, Virginia, and West Virginia have also classified bromazolam as a Schedule 1 controlled substance.
Key Features of Bromazolam Classification
| Feature | Details |
|---|---|
| Designation | Schedule 1 Controlled Substance |
| Reason for Classification | High potential for abuse, no accepted medical use |
| Reported Deaths in 2024 | 48 deaths linked to bromazolam |
| States Following Suit | Nevada, New Mexico, North Dakota, Virginia, West Virginia |
| Governor’s Initiative | Part of ongoing efforts to combat addiction in Kentucky |
Deeper Dive: News & Info About This Topic
HERE Resources
Additional Resources
- Kentucky.com: Bromazolam Classification
- Wikipedia: Bromazolam
- AP News: Designer Xanax
- Google Search: Bromazolam
- News Nation: Bromazolam Schedule 1
- Encyclopedia Britannica: Benzodiazepine
- Kentucky.com: Education Local News
- Google News: Bromazolam Kentucky
Author: STAFF HERE BOWLING GREEN WRITER
The BOWLING GREEN STAFF WRITER represents the experienced team at HEREBowlingGreen.com, your go-to source for actionable local news and information in Bowling Green, Warren County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as the National Corvette Homecoming, International Festival, concerts at SKyPAC, and sports events at Beech Bend Park. Our coverage extends to key organizations like the Bowling Green Area Chamber of Commerce and the African American Museum Bowling Green Area, plus leading businesses in automotive, apparel, and healthcare that power the local economy such as General Motors Corvette Assembly Plant, Fruit of the Loom, and Med Center Health. As part of the broader HERE network, including HERELexingtonKY.com and HERELouisville.com, we provide comprehensive, credible insights into Kentucky's dynamic landscape.
